Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Ryder

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|April 24, 2023
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trialLouise China, Thais Tittanegro, Dominic Crocombe, et al.
The American Journal of Gastroenterology|August 15, 2022
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE TrialRishen Kutmutia, Thais Tittanegro, Louise China, et al.
Journal of Hepatocellular Carcinoma|May 8, 2023
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma SurveillanceRobert A Scott, Timothy J S Cross, Christopher Clarke, et al.
International Journal of Technology Assessment in Health Care|April 1, 2009
Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practiceMarina Grishchenko, Richard D Grieve, Michael J Sweeting, et al.
Frontline Gastroenterology|October 19, 2023
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveysKushala W M Abeysekera, Ankur Srivastava, Ian Rowe, et al.
Plos One|December 29, 2012
The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI)David J McLernon, John F Dillon, Frank M Sullivan, et al.
European Journal of Gastroenterology & Hepatology|February 17, 2012
Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosisSudeep Tanwar, Mark Wright, Graham R Foster, et al.
Qualitative Health Research|September 8, 2023
Application and Extension of the Alcohol Recovery Narratives Conceptual FrameworkMohsan Subhani, Usman Talat, Holly Knight, et al.
Journal of Hepatology|April 3, 2007
The natural history of hepatitis C with severe hepatic fibrosisAdam Lawson, Simone Hagan, Kara Rye, et al.
Journal of Clinical Medicine|January 8, 2025
Screening for Alcohol Use Disorder Among Hospitalised Patients: Learning from a Retrospective Cohort Study in Secondary CareMohsan Subhani, Dipaka Rani Nath, Usman Talat, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|April 24, 2023
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trialLouise China, Thais Tittanegro, Dominic Crocombe, et al.
The American Journal of Gastroenterology|August 15, 2022
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE TrialRishen Kutmutia, Thais Tittanegro, Louise China, et al.
Journal of Hepatocellular Carcinoma|May 8, 2023
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma SurveillanceRobert A Scott, Timothy J S Cross, Christopher Clarke, et al.
International Journal of Technology Assessment in Health Care|April 1, 2009
Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practiceMarina Grishchenko, Richard D Grieve, Michael J Sweeting, et al.
Frontline Gastroenterology|October 19, 2023
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveysKushala W M Abeysekera, Ankur Srivastava, Ian Rowe, et al.
Plos One|December 29, 2012
The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI)David J McLernon, John F Dillon, Frank M Sullivan, et al.
European Journal of Gastroenterology & Hepatology|February 17, 2012
Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosisSudeep Tanwar, Mark Wright, Graham R Foster, et al.
Qualitative Health Research|September 8, 2023
Application and Extension of the Alcohol Recovery Narratives Conceptual FrameworkMohsan Subhani, Usman Talat, Holly Knight, et al.
Journal of Hepatology|April 3, 2007
The natural history of hepatitis C with severe hepatic fibrosisAdam Lawson, Simone Hagan, Kara Rye, et al.
Journal of Clinical Medicine|January 8, 2025
Screening for Alcohol Use Disorder Among Hospitalised Patients: Learning from a Retrospective Cohort Study in Secondary CareMohsan Subhani, Dipaka Rani Nath, Usman Talat, et al.
Pageof 8